883 - Keras Resources #KRS ImmuPharma #IMM Defenx #DFX Mi-Pay #MPAY

Sep 27, 2017, 11:50 AM

On the Vox Markets Podcast Today - 27th September 2017

Dave Reeves, Managing Director of Keras Resources #KRS talks about the A$10m placement of Calidus Resources and what he sees as a valuation disconnect. (Interview starts at 1 minute 31 seconds)

Tim McCarthy, Chairman of Immupharma #IMM reflects on their interim results and gives an update on their lead drug, Lupuzor™ which is currently in its Phase III pivotal trial. (Interview starts at 6 minutes 58 seconds)

Philipp Prince, Chief Financial Officer of Defenx Group #DFX covers some of the highlights from their interim results and goes through the detail on their master services agreement with BV-Tech. (Interview starts at 18 minutes 51 seconds)

Michael Dickerson, CEO and John Beale, CFO of Mi-Pay #MPAY go over their interim results and also talk about the outlook in the world of mobile payment solutions. (Interview starts at 24 minutes 51 seconds)

Plus the Top 5 Most Followed Companies on Vox Markets in the last 24 hours & the Top 5 Most Liked RNS’s on Vox Markets in the last 24 hours. (Feature starts at 35 minutes 3 seconds)

Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Finance #Business #Podcast